Results 111 to 120 of about 11,837 (160)

Exposure to ceftazidime-avibactam induced antimicrobial resistance and enhanced virulence in a <i>Klebsiella pneumoniae</i> strain. [PDF]

iScience
Li J, Wang H, Liu Z, Xia Y, Hu Y, Wang H, Xia F, Zou M.   +7 more
europepmc   +1 more source

Molecular epidemiology of carbapenem-resistant hypervirulent <i>Klebsiella pneumoniae</i>: risk factors and resistance mechanism of ceftazidime/avibactam in China. [PDF]

Front Cell Infect Microbiol
Wang N, Deng L, Li H, Jia N, Peng X, Chang J, Hao J, Tang J, Lei C, Wang B, Liu J, Zhang W.   +11 more
europepmc   +1 more source

Ceftazidime-Avibactam Regimens for the Treatment of Bacteremic and Non-Bacteremic Episodes of Carbapenemase-Producing Enterobacterales Infections in Immunosuppressed Patients. [PDF]

Pathogens
Herrera F, Torres D, Leone M, Castro MG, Camelo JL, Temporiti E, Grippo N, Relloso S, Bonvehí P.   +8 more
europepmc   +1 more source

The impact of ceftazidime-avibactam on 30-day mortality in the treatment of OXA-48 producing <i>Enterobacterales</i> infections: a systematic review and meta-analysis. [PDF]

JAC Antimicrob Resist
Foo AL, Young B, Ng OT, Vasoo S.
europepmc   +1 more source

Successful dual therapy of aztreonam and ceftazidime-avibactam for multidrug-resistant <i>Stenotrophomonas maltophilia</i> infection in a preterm neonate: A life-saving approach. [PDF]

J Int Med Res
Alghamdi AO, Algethami AS, Aljuaeed MS, Alkhammash FM, Almalki FM, Alharthi SA, Aljaed NM, Abosabie SA, Abosabie SA, Kamal NM.   +9 more
europepmc   +1 more source

Effectiveness and safety of meropenem-vaborbactam versus ceftazidime-avibactam in multidrug-resistant Gram-negative infections: a systematic review and meta-analysis with trial sequential analysis. [PDF]

Antimicrob Agents Chemother
Mohammad S, Al Namer Y, Rahimeh W, Albalas M, Almangour TA.   +4 more
europepmc   +1 more source

Antimicrobial Resistance Profiles of <i>Pseudomonas aeruginosa</i> in a Korean Community Hospital: <i>In Vitro</i> Activity of Ceftazidime-Avibactam and Other Agents. [PDF]

Pol J Microbiol
Lee HJ, Cho SY, Lee DG, Park C, Byun J, Chun HS, Kim YR.   +6 more
europepmc   +1 more source

OmpK35/36 absence does not confer carbapenem-resistance alone nor ceftazidime-avibactam resistance with one <i>bla</i> _KPC-2. [PDF]

Front Cell Infect Microbiol
Wu S, Yang Y, Xiang W, Zhang J, Luo X, Xu M, Hu D, Zhang H.   +7 more
europepmc   +1 more source

Analysis of a simple disk diffusion method to evaluate ceftazidime-avibactam/aztreonam combination synergism against New Delhi metallo-beta-lactamase-producing clinical isolates. [PDF]

Access Microbiol
Rajan R, Gopinathan S, Rao AVR, B R, Mathavi S.   +4 more
europepmc   +1 more source

Novel KPC-2 variants and epidemic ST463 clones underlie ceftazidime/avibactam resistance in carbapenem-resistant <i>Pseudomonas aeruginosa</i>. [PDF]

Microbiol Spectr
Hu Y, Sun Q, Shen W, Du J, Kaiqi Z, Zhang R.   +5 more
europepmc   +1 more source